Industry

DUBLIN–(BUSINESS WIRE)–The “Healthcare Interoperability Solutions Market Research Report by Component (Services and Software), Level, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Interoperability Solutions Market size was estimated at USD 2,934.37 million in … [Read more…]

Water Bottle Caps with Integrated Deep UV LEDs Recognized for Excellence in Business to Consumer: Travel, Sports & Outdoor Goods BERLIN–(BUSINESS WIRE)–#sustainablehydration–During an awards ceremony on May 24, 2022, the German Innovation Awards named both WAATR PureMax 4D and CrazyCap as winners in Business to Consumer: Travel, Sports & Outdoor Goods. The German Innovation Award … [Read more…]

13 of 16 metastatic Uveal Melanoma (UM) patients continue in trial with promising overall survival rate at 1 year Excellent safety allowed for chronic administration with no dose alterations, achieving intended pharmacological effect Tregs reduced by IOA-244 in peripheral blood and tumor tissue, supporting mechanism of action GENEVA, Switzerland–(BUSINESS WIRE)–iOnctura SA, a clinical-stage oncology company … [Read more…]

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that an abstract reporting preliminary data from the two Phase I trials assessing TG4050, its individualized neoantigen cancer vaccine, has been selected for a poster presentation at the American Society of Clinical … [Read more…]

HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022. Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021   The quarter ended March 31, 2022, includes one month’s results from the February 28th acquisition of Alchemee. … [Read more…]

– ALPN-303 Novel Preclinical Data and Preliminary Phase 1 Data at EULAR – – Davoceticept (ALPN-202) Monotherapy Update and Trials in Progress Poster for Pembrolizumab Combination Study at ASCO – SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today … [Read more…]

– Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months – Study sites are open for patient enrolment LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today … [Read more…]

NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced three Flatiron-authored abstracts have been accepted for poster discussion and presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7. “As demonstrated by our research at ASCO this year, we are at the forefront of our industry to improve patient lives through … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the publication of preclinical data on AU-011, its first VDC product candidate, in combination with immune checkpoint inhibitors. AU-011 is being developed for the treatment of life-threatening cancers … [Read more…]

– Randomized Phase 3 Clinical Trial of ADCETRIS Combination Met Key Secondary OS Endpoint, Demonstrating a 41% Reduction in Risk of Death vs. Standard of Care in Patients With Advanced Hodgkin Lymphoma – CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival … [Read more…]